cagrilintide and semaglutide 2.4 mg Efficacy safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study Sema + Cagri 2 mg+2

To view a copy of this license, visit About this article Cite this article Mischley, L., Conley, K., Shankland, E

Diarrhoea Diarrhoea can also occur as your body adjusts to the medication

Industry officials expect the price competition to lower the monthly cost for starting doses to the 200,000-300,000 won range

This will be determined between you and the practitioner during your initial appointment

Interesting to see how this behaves as a commercial product

Yeo suggests thinking about weight-loss drugs as a tool for people to build healthier lifestyles while they are on them, with the goal of making it easier to come off the drugs and maintain the weight